title: Chronic phase chronic myeloid leukemia patients who failed interferon alpha and switched to imatinib: Long-term 9-year follow-up of 134 patients.
authors: Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.
authors: Massimo
authors: M
authors: Breccia
authors: Roberto
authors: R
authors: Latagliata
authors: Matteo
authors: M
authors: Molica
authors: Gioia
authors: G
authors: Colafigli
authors: Marco
authors: M
authors: Mancini
authors: Daniela
authors: D
authors: Diverio
authors: Agostino
authors: A
authors: Tafuri
authors: Giuliana
authors: G
authors: Alimena
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides / Q000627:therapeutic use*; D000069439:Dasatinib; D019008:Drug Resistance, Neoplasm; D057915:Drug Substitution; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000068877:Imatinib Mesylate; D016898:Interferon-alpha / Q000627:therapeutic use; D015466:Leukemia, Myeloid, Chronic-Phase / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D016019:Survival Analysis; D013844:Thiazoles / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D016898:Interferon-alpha; D010879:Piperazines; D011743:Pyrimidines; D013844:Thiazoles; D000068877:Imatinib Mesylate; C498826:nilotinib; D000069439:Dasatinib